New all-Time High: Axon Enterprise (AXON) is Experiencing High Demand for the TASER 10 Stun gun and is Significantly Expanding its Addressable Market Through Acquisitions.

Axon Enterprise (AXON) remains a leader stock. The company focuses on the development of law enforcement technologies, including stun guns (Tasers) and body cameras. Its business model comprises the sale of these products as well as cloud-based software solutions for managing the resulting data. The company has set itself the goal of reducing the number of deaths in civilian police encounters by 50% within 10 years.

In the future, the company wants to solve challenges at a higher level. This includes better decision making in potentially life-threatening encounters or the effective expansion of police forces by reducing the amount of time spent on paperwork. AXON wants to speed up the entire justice system and is working on innovations in various areas, from robotic security to generative AI and virtual reality. Axon is already using AI to offer features such as facial recognition and behavioral analysis. The acquisitions of Fusus and Sky-Hero provide Axon with strategic advantages in several key areas. Fusus expands Axon's capabilities in the areas of real-time operations and critical event management. Sky-Hero strengthens Axon's product offering in drone technology, a key focus area for the company. Together, the acquisitions will increase the estimated addressable market (TAM) by over $13 billion to a total of $63 billion.

AXON once again reported better than expected Q4 figures on Tuesday evening (February 27) after the close of trading. The company thus closed its fifth consecutive year with sales growth of more than 25 % and significantly exceeded its earnings growth of 31 % compared to the previous year. This growth is being driven by the TASER 10 distance electropulse device, among other things. For four quarters in a row, the order rate was more than four times as high as for TASER 7. Demand for the Axon Body 4 - Body-Cam is another factor. The company expects to achieve annual sales growth of at least 20% even after 2024 and continues to aim for an adjusted EBITDA margin of around 25%. Analysts at JMP Securities raised their price target for Axon from $285 to $320.

Axon Enterprise (ISIN US05464C1018): The stock looks absolutely bullish and both the 2023 results and the outlook look strong. EPS is expected to more than triple by 2025. The share is once again breaking out to a new all-time high.

Want to keep reading?

You can find the entire story in The Trader Times. Get a 4-week trial subscription now and access the entire archive!